FFA
ORKA

Farther Finance Advisors’s Oruka Therapeutics ORKA Stock Holding History

Farther Finance Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99K Buy
21
+9
+75% +$600 ﹤0.01% 5169
2026
Q1 		$605 Buy
12
+2
+20% +$70 ﹤0.01% 5226
2025
Q4 		$303 Hold
10
– – ﹤0.01% 5137
2025
Q3 		$192 Buy
+10
New +$148 ﹤0.01% 4726

Other funds holding ORKA

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's ORKA Position: Q2 2026 in Review

Farther Finance Advisors increased its Oruka Therapeutics (ORKA) stake by 75% in Q2 2026, buying an estimated $600 and bringing the position to 21 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #5169.

Farther Finance Advisors first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Farther Finance Advisors held 21 shares of Oruka Therapeutics worth $1.99K as of Q2 2026.
  • Farther Finance Advisors bought 9 Oruka Therapeutics shares in Q2 2026, an estimated $600.
  • Oruka Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5169 holding.
  • Farther Finance Advisors first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.